Deciphera Pharmaceuticals (DCPH) Short Interest Ratio & Short Volume → Watch this FREE trading tutorial while it’s still available (From InvestorPlace) (Ad) Free DCPH Stock Alerts $25.37 -0.01 (-0.04%) (As of 05/6/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Deciphera Pharmaceuticals Short Interest DataCurrent Short Volume5,750,000 sharesPrevious Short Volume6,060,000 sharesChange Vs. Previous Month-5.12%Dollar Volume Sold Short$85.68 millionShort Interest Ratio / Days to Cover10.9Last Record DateApril 15, 2024Outstanding Shares82,230,000 sharesFloat Size50,240,000 sharesShort Percent of Float11.45%Today's Trading Volume1,541,663 sharesAverage Trading Volume1,241,940 sharesToday's Volume Vs. Average124% Short Selling Deciphera Pharmaceuticals ? Sign up to receive the latest short interest report for Deciphera Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatDCPH Short Interest Over TimeDCPH Days to Cover Over TimeDCPH Percentage of Float Shorted Over Time Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story Deciphera Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20245,750,000 shares $85.68 million -5.1%11.5%10.9 $14.90 3/31/20246,060,000 shares $95.32 million +7.3%12.3%11.2 $15.73 3/15/20245,650,000 shares $88.08 million +2.5%11.4%10.6 $15.59 2/29/20245,510,000 shares $91.96 million No Change11.2%9.8 $16.69 2/15/20245,510,000 shares $87.72 million +3.2%11.2%10 $15.92 1/31/20245,340,000 shares $76.47 million +7.4%10.9%9.6 $14.32 Get the Latest News and Ratings for DCPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Deciphera Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20244,970,000 shares $73.75 million +1.2%10.2%7.5 $14.84 12/31/20234,910,000 shares $79.20 million +0.4%10.1%6.9 $16.13 12/15/20234,890,000 shares $78.00 million -15.0%10.1%6.8 $15.95 11/30/20235,750,000 shares $72.51 million +3.6%11.9%8.2 $12.61 11/15/20235,550,000 shares $68.49 million +41.9%11.5%8.6 $12.34 10/31/20233,910,000 shares $46.88 million -3.0%8.1%6 $11.99 10/15/20234,030,000 shares $44.13 million -0.3%8.5%7.9 $10.95 9/30/20234,040,000 shares $51.39 million -7.1%8.5%8.6 $12.72 9/15/20234,350,000 shares $58.38 million +2.4%9.1%10.6 $13.42 8/31/20234,250,000 shares $59.67 million +4.2%7.8%9.9 $14.04 8/15/20234,080,000 shares $63.16 million -1.0%7.5%9.1 $15.48 7/31/20234,120,000 shares $55.70 million +6.5%7.6%9.3 $13.52 7/15/20233,870,000 shares $54.22 million +2.1%7.1%7.8 $14.01 6/30/20233,790,000 shares $53.36 million -14.1%6.7%7.1 $14.08 6/15/20234,410,000 shares $64.12 million +2.3%8.1%7.9 $14.54 5/31/20234,310,000 shares $58.19 million +14.9%8.0%6.9 $13.50 5/15/20233,750,000 shares $53.33 million +11.0%7.0%5.8 $14.22 4/30/20233,380,000 shares $48.03 million +0.3%6.3%4.9 $14.21 4/15/20233,370,000 shares $49.00 million -40.9%6.5%4.5 $14.54 3/31/20235,700,000 shares $88.07 million +6.9%11.0%7.1 $15.45 3/15/20235,330,000 shares $89.22 million -0.7%10.3%6.3 $16.74 2/28/20235,370,000 shares $77.87 million No Change10.3%6.9 $14.50 2/15/20235,370,000 shares $83.13 million +7.6%10.4%7.1 $15.48 1/31/20234,990,000 shares $84.88 million +4.8%10.8%6.9 $17.01 1/15/20234,760,000 shares $102.34 million -33.7%10.0%7 $21.50 12/30/20227,180,000 shares $117.68 million -6.5%15.1%12.4 $16.39 12/15/20227,680,000 shares $120.58 million +7.7%16.1%13.9 $15.70 11/30/20227,130,000 shares $113.44 million -2.9%15.0%11 $15.91 11/15/20227,340,000 shares $115.53 million +2.4%15.5%10.4 $15.74 10/31/20227,170,000 shares $116.30 million -2.9%15.1%9.4 $16.22 10/15/20227,380,000 shares $123.47 million -1.9%15.7%9.1 $16.73 9/30/20227,520,000 shares $139.12 million +0.8%16.0%8.9 $18.50 9/15/20227,460,000 shares $147.86 million -5.1%15.9%8.4 $19.82 8/31/20227,860,000 shares $127.57 million +9.6%16.8%8.4 $16.23Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. DCPH Short Interest - Frequently Asked Questions What is Deciphera Pharmaceuticals' current short interest? Short interest is the volume of Deciphera Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 5,750,000 shares of DCPH short. 11.45% of Deciphera Pharmaceuticals' shares are currently sold short. Learn More on Deciphera Pharmaceuticals' current short interest. What is a good short interest ratio for Deciphera Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DCPH shares currently have a short interest ratio of 11.0. Learn More on Deciphera Pharmaceuticals's short interest ratio. Which institutional investors are shorting Deciphera Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Deciphera Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Deciphera Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.45% of Deciphera Pharmaceuticals' floating shares are currently sold short. Is Deciphera Pharmaceuticals' short interest increasing or decreasing? Deciphera Pharmaceuticals saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 5,750,000 shares, a drop of 5.1% from the previous total of 6,060,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Deciphera Pharmaceuticals' float size? Deciphera Pharmaceuticals currently has issued a total of 82,230,000 shares. Some of Deciphera Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Deciphera Pharmaceuticals currently has a public float of 50,240,000 shares. How does Deciphera Pharmaceuticals' short interest compare to its competitors? 11.45% of Deciphera Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Deciphera Pharmaceuticals: Maravai LifeSciences Holdings, Inc. (5.93%), TG Therapeutics, Inc. (25.55%), Keros Therapeutics, Inc. (6.27%), Amphastar Pharmaceuticals, Inc. (11.01%), Geron Co. (8.33%), Vera Therapeutics, Inc. (16.07%), Arvinas, Inc. (13.09%), Dyne Therapeutics, Inc. (10.32%), Rocket Pharmaceuticals, Inc. (12.12%), NewAmsterdam Pharma (0.85%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Deciphera Pharmaceuticals stock? Short selling DCPH is an investing strategy that aims to generate trading profit from Deciphera Pharmaceuticals as its price is falling. DCPH shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Deciphera Pharmaceuticals? A short squeeze for Deciphera Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DCPH, which in turn drives the price of the stock up even further. How often is Deciphera Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DCPH, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Maravai LifeSciences Short Interest Data TG Therapeutics Short Interest Data Keros Therapeutics Short Interest Data Amphastar Pharmaceuticals Short Interest Data Geron Short Interest Data Vera Therapeutics Short Interest Data Arvinas Short Interest Data Dyne Therapeutics Short Interest Data Rocket Pharmaceuticals Short Interest Data NewAmsterdam Pharma Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DCPH) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressThe 2024 crypto bull run has already started — don’t get left behindInvestorPlaceThe asset beating inflation by 4xColonial MetalsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & Company